Related Experiment Video
Updated: Jul 25, 2026
10:35
Stereotactic Radiosurgery for Gynecologic Cancer
Published on: April 17, 2012
Radioimmunoguided surgery for colorectal cancer
R C Manayan1, M J Hart, W G Friend
1Swedish Hospital Medical Center, Seattle, Washington, USA.
American Journal of Surgery
|May 1, 1997
Summary
Radioimmunoguided surgery (RIGS) improves colorectal cancer staging. This technique accurately detects cancer lesions, aiding surgeons in complete tumor resection and potentially improving patient survival rates.
Area of Science:
- Oncology
- Surgical Oncology
- Medical Imaging
Background:
- Accurate cancer staging and complete lesion resection are crucial for improving survival rates in surgical cancer treatments.
- Radioimmunoguided surgery (RIGS) is an emerging technique for colorectal cancer treatment.
- A multicenter trial is currently evaluating RIGS for colorectal cancer.
Purpose of the Study:
- To evaluate the effectiveness of RIGS in detecting colorectal cancer lesions.
- To assess the impact of RIGS on disease staging and surgical decision-making.
Main Methods:
- Twenty-eight patients with primary or recurrent colorectal cancer were enrolled.
- Patients received an injection of iodine 125-labeled monoclonal antibody CC49.
- Intraoperative detection of radiolabeled antibody was performed using a hand-held gamma-detecting probe during both traditional and RIGS explorations.
Main Results:
- RIGS detected radiolabeled antibody in 73% of primary colorectal cancer patients and 100% of recurrent disease patients.
- RIGS led to upstaging in 26% of primary cancer patients, from stage I/II to stage III/IV.
- RIGS provided immediate, valuable information not obtainable through conventional methods.
Conclusions:
- RIGS demonstrates significant potential in enhancing the accuracy of colorectal cancer staging.
- The technique offers immediate intraoperative information, aiding surgeons in treatment planning.
- Further analysis of the ongoing phase III trial will provide more comprehensive outcomes.
